{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:37Z","timestamp":1772160577157,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R13 MH074345"],"award-info":[{"award-number":["R13 MH074345"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent reports have linked the use of phosphodiesterase type 5 (PDE-5) inhibitors with increased rates of high-risk sexual behavior and HIV transmission in some individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>A National Institute of Mental Health (NIMH)-funded, multidisciplinary conference was convened to evaluate scientific research, clinical and ethical considerations, and public policy implications of this topic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Published and unpublished findings on effects of PDE-5 inhibitors on sexual behavior; published guidelines and management recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Leading investigators in relevant disciplines (e.g., public health, epidemiology, medical ethics, urology, psychology) participated in a 2-day meeting, including representatives of government, scientific, and regulatory agencies (the Centers for Disease Control, Food and Drug Administration, NIMH, and the National Institute on Drug Abuse). Panelists provided critical reviews of substantive areas of research, followed by question and answer sessions on each topic. On the second day, working groups were convened to identify critical gaps and priorities in three major areas: (i) research and evaluation needs; (ii) prevention strategies and clinical management issues; and (iii) policy and prevention implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Research needs and priorities were categorized into four specific areas: (i) basic and clinical\/laboratory research; (ii) epidemiology and risk factors; (iii) social-behavioral processes and interventions; and (iv) prevention\/policy and educational needs. Identified gaps in the available data include populations at risk (e.g., risk among heterosexuals, risk profiles among subpopulations of men who have sex with men) and the specific role of PDE-5 inhibitors in HIV seroconversion. Specific areas of emphasis were the need for safer sex counseling, comprehensive sexually transmitted infection (STI) screening and follow-up when indicated, avoidance of potentially dangerous drug interactions, and potential benefits of testosterone replacement for HIV-positive men with decreased androgen and other symptoms of hypogonadism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A conference was convened on the topic of PDE-5 inhibition and HIV risk. This \u201cwhite paper\u201d summarizes the findings of the conference and recommendations for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2006.00323.x","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T06:45:27Z","timestamp":1161845127000},"page":"960-975","source":"Crossref","is-referenced-by-count":26,"title":["The Bolger Conference on PDE-5 Inhibition and HIV Risk: Implications for Health Policy and Prevention"],"prefix":"10.1093","volume":"3","author":[{"given":"Raymond C.","family":"Rosen","sequence":"first","affiliation":[{"name":"Department of Psychiatry Robert Wood Johnson Medical School New England Research Institutes , Watertown"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Catania","sequence":"additional","affiliation":[{"name":"Center for AIDS Prevention Studies Department of Medicine , San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke A.","family":"Ehrhardt","sequence":"additional","affiliation":[{"name":"HIV Center for Clinical and Behavioral Studies New York State Psychiatric Institute Columbia University , New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[{"name":"Department of Urology The Johns Hopkins Hospital , Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom F.","family":"Lue","sequence":"additional","affiliation":[{"name":"Department of Urology University of California , San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"McKenna","sequence":"additional","affiliation":[{"name":"Departments of Physiology and Urology Northwestern University Medical School , Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia R.","family":"Heiman","sequence":"additional","affiliation":[{"name":"Kinsey Institute for Research in Sex Gender and Reproduction Indiana University , Bloomington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Schwarcz","sequence":"additional","affiliation":[{"name":"HIV\/AIDS Statistics and Epidemiology San Francisco Public Health Department , San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Ostrow","sequence":"additional","affiliation":[{"name":"David Ostrow & Associates , Lakewood"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Hirshfield","sequence":"additional","affiliation":[{"name":"Medical and Health Research Association , New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Purcell","sequence":"additional","affiliation":[{"name":"Prevention Research Branch Division of HIV\/AIDS Prevention Centers for Disease Control and Prevention , Atlanta , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Departments of Psychology and Obstetrics and Gynecology University of Western Ontario , London, Ontario , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Stall","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Community Health Sciences University of Pittsburgh , Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry N.","family":"Halkitis","sequence":"additional","affiliation":[{"name":"Center for Health, Identity, Behavior and Prevention Studies (CHIBPS) New York University , New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Latini","sequence":"additional","affiliation":[{"name":"Scott Department of Urology Baylor College of Medicine , Houston , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Elford","sequence":"additional","affiliation":[{"name":"City University Institute of Health Sciences , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward O.","family":"Laumann","sequence":"additional","affiliation":[{"name":"Department of Sociology University of Chicago , Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freya L.","family":"Sonenstein","sequence":"additional","affiliation":[{"name":"Center for Adolescent Health The Johns Hopkins Bloomberg School of Public Health , Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Experimental Therapeutics Tufts University , Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Kloner","sequence":"additional","affiliation":[{"name":"Keck School of Medicine University of Southern California , Los Angeles , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Lee","sequence":"additional","affiliation":[{"name":"Private Practice , Calgary Alberta , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Malebranche","sequence":"additional","affiliation":[{"name":"Department of Medicine Emory University , Atlanta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Janssen","sequence":"additional","affiliation":[{"name":"Kinsey Institute for Research in Sex Gender and Reproduction Indiana University , Bloomington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[{"name":"Cesar Chavez Institute San Francisco State University , San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Klausner","sequence":"additional","affiliation":[{"name":"STD Prevention and Control Services San Francisco Department of Public Health , San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Caplan","sequence":"additional","affiliation":[{"name":"Center for Bioethics University of Pennsylvania , Philadelphia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Jackson","sequence":"additional","affiliation":[{"name":"Saint Thomas Hospital , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridwan","family":"Shabsigh","sequence":"additional","affiliation":[{"name":"Department of Urology, Columbia Presbyterian Medical Center Columbia University , New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jag H.","family":"Khalsa","sequence":"additional","affiliation":[{"name":"Medical Consequences Branch National Institute on Drug Abuse , Bethesda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Stoff","sequence":"additional","affiliation":[{"name":"Center for Mental Health Research on AIDS National Institute of Mental Health , Bethesda , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2024032600165306500_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1939-4640.2002.tb02292.x","article-title":"Nitric oxide regulation of penile erection: Biology and therapeutic implications","volume":"23","author":"Burnett","year":"2002","journal-title":"J Androl"},{"key":"2024032600165306500_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1743-6109.2005.20103.x","article-title":"Pathophysiology of erectile dysfunction","volume":"2","author":"Saenz de Tejada","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600165306500_bib3","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600165306500_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1743-6109.2004.10106.x","article-title":"Epidemiology\/risk factors of sexual dysfunction","volume":"1","author":"Lewis","year":"2004","journal-title":"J Sex Med"},{"issue":"Suppl.","key":"2024032600165306500_bib5","first-page":"9M","article-title":"Overview of phosphodiesterase 5 inhibition in erectile dysfunction","volume":"92","author":"Rosen","year":"2004","journal-title":"Am J Cardiology"},{"key":"2024032600165306500_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2005.00149.x","article-title":"Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600165306500_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease: The Princeton Consensus Panel","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiology"},{"key":"2024032600165306500_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","article-title":"The 2nd Princeton Consensus Panel: Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiology"},{"key":"2024032600165306500_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"1","author":"Lue","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600165306500_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1743-6109.2005.20110.x","article-title":"Sildenafil citrate response correlates with the nature and the severity of penile vascular insufficiency","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600165306500_bib11","first-page":"907","article-title":"The continuing HIV epidemic among men who have sex with men","volume":"1","author":"Catania","year":"2001","journal-title":"Am J Public Health"},{"key":"2024032600165306500_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1080\/09540120412331292525","article-title":"Substance use and high-risk sex among men who have sex with men: A national online study in the USA","volume":"16","author":"Hirshfield","year":"2004","journal-title":"AIDS Care"},{"key":"2024032600165306500_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J082v41n02_02","article-title":"A double epidemic: Crystal methamphetamine drug use in relation to HIV transmission among gay men","volume":"41","author":"Halkitis","year":"2001","journal-title":"J Homosex"},{"key":"2024032600165306500_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1258\/0956462042395221","article-title":"Factors associated with sexual problems in HIV positive men gay men","volume":"15","author":"Cove","year":"2004","journal-title":"Int J STD AIDS"},{"key":"2024032600165306500_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1D571","article-title":"Recreational use of sildenafil by HIV-positive and -negative hormosexual\/bisexual males","volume":"38","author":"Romanelli","year":"2004","journal-title":"Ann Pharmacotherapy"},{"key":"2024032600165306500_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjmed.2005.01.042","article-title":"Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection","volume":"118","author":"Swearingen","year":"2005","journal-title":"Am J Med"},{"key":"2024032600165306500_bib17","article-title":"Recreational use of Viagra is associated with HIV seroconversion in San Francisco. In: XV International Aids Conference","volume-title":"Bangkok, Thailand.","author":"Loeb","year":"2004"},{"key":"2024032600165306500_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/apc.2005.19.869","article-title":"A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: Diagnosis, pathogenesis, and management","volume":"19","author":"Crum","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"2024032600165306500_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00126334-200211010-00008","article-title":"Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy","volume":"31","author":"Collazos","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024032600165306500_bib20","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00593-0","article-title":"Sexual dysfunction with protease inhibitors","volume":"353","author":"Martinez","year":"1999","journal-title":"Lancet"},{"key":"2024032600165306500_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00042560-200206010-00007","article-title":"Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors","volume":"30","author":"Lallemand","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024032600165306500_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/09540129408258030","article-title":"Sexual dysfunction in advanced HIV disease","volume":"6","author":"Tindall","year":"1994","journal-title":"AIDS Care"},{"key":"2024032600165306500_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00224499709551862","article-title":"Do no harm: On the ethics of testosterone replacement therapy for HIV+ persons","volume":"24","author":"Fisher","year":"1997","journal-title":"J Sex Res"},{"key":"2024032600165306500_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1345\/aph.1A402","article-title":"Neurologic, psychological and aggressive disturbances with sildenafil","volume":"36","author":"Milman","year":"2002","journal-title":"Ann Pharmacother"},{"key":"2024032600165306500_bib25","article-title":"Methamphetamine and combinations of drugs and HIV seroincidence in the MACS study.","author":"Ostrow","year":"2006"},{"issue":"Suppl. 1","key":"2024032600165306500_bib26","first-page":"s27","article-title":"Illicit substance use, sexual risk and HIV-positive gay and bisexual men: Differences by serostatus of casual partners","volume":"19","author":"Purcell","year":"2005","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"2024032600165306500_bib27","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1097\/01.aids.0000167352.08127.76","article-title":"Predictors of the use of Viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men","volume":"19","author":"Purcell","year":"2005","journal-title":"AIDS"},{"key":"2024032600165306500_bib28","first-page":"26","article-title":"Does PDE-5 inhibitor use predict unprotected sex among men who have sex with men? A preliminary report of a national online study.","volume-title":"Paper Presented at: PDE-5 Inhibition and HIV Risk: Current concepts and controversies","author":"Hirshfield","year":"2005"},{"key":"2024032600165306500_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00126334-200306010-00012","article-title":"Viagra use in a community-recruited sample of men who have sex with men, San Francisco","volume":"33","author":"Chu","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024032600165306500_bib30","first-page":"661","article-title":"Viagra use and HIV risk among older gay\/bi men: Research and practice implications from a mixed method inquiry","volume":"45","author":"Coon","year":"2005","journal-title":"Gerontologist"},{"key":"2024032600165306500_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00126334-200112010-00011","article-title":"Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison","volume":"28","author":"Colfax","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024032600165306500_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/sti.2004.010785","article-title":"Trends in sexual behaviour among London homosexual men 1998\u20132003: Implications for HIV prevention and sexual health promotion","volume":"80","author":"Elford","year":"2004","journal-title":"Sex Transm Infect"},{"key":"2024032600165306500_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1026041628364","article-title":"Sexual risk taking in gay men: The relevance of sexual arousability, mood and sensation seeking","volume":"32","author":"Bancroft","year":"2003","journal-title":"Arch Sex Behav"},{"key":"2024032600165306500_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/00224490409552226","article-title":"Sexual risk taking in young heterosexual men: The relevance of sexual arousability, mood and sensation seeking","volume":"41","author":"Bancroft","year":"2004","journal-title":"J Sex Res"},{"key":"2024032600165306500_bib35","doi-asserted-by":"crossref","first-page":"1019.","DOI":"10.1097\/00002030-200105250-00010","article-title":"Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment","volume":"15","author":"Schrooten","year":"2001","journal-title":"AIDS"},{"key":"2024032600165306500_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000192000.15777.5c","article-title":"Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients","volume":"41","author":"Fisher","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 3","key":"2024032600165306500_bib37","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijir.3900562","article-title":"Lecture 5: Erectile dysfunction in the HIV-positive male: A review of medical, legal and ethical considerations in the age of oral pharmacotherapy","volume":"12","author":"Sadeghi-Nejad","year":"2000","journal-title":"[Lectures] Int J Impot Res"},{"key":"2024032600165306500_bib38","article-title":"Viagra, methamphetamine and HIV risk: results from a probability sample of MSM, San Francisco","volume-title":"Sexually Transmitted Diseases","author":"Spindler"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515314211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515314211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/6\/960\/47737107\/jsm_3_6_960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/6\/960\/47737107\/jsm_3_6_960.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:11:21Z","timestamp":1711401081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/3\/6\/960\/6883111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00323.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1055715.507629","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1055715.511141","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,11]]},"published":{"date-parts":[[2006,11,1]]}}}